{
    "organizations": [],
    "uuid": "4e3dc3fef2fc5f7254e615fdcd3c5250ee15b821",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-boehringer-ingelheim-to-invest-eur/brief-boehringer-ingelheim-to-invest-eur-65-mln-in-avian-vaccines-idUSFWN1RO0T8",
    "ord_in_thread": 0,
    "title": "BRIEF-Boehringer Ingelheim To Invest EUR 65 Mln In Avian Vaccines",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - Boehringer Ingelheim:\n* BOEHRINGER INGELHEIM TO INVEST €65 MILLION IN AVIAN VACCINES\n* BOEHRINGER INGELHEIM SAYS IT IS SET TO INVEST ALMOST EUR 65 MLN AT ITS LYON PORTE-DES-ALPES SITE IN SAINT-PRIEST, FRANCE (RHÔNE) Source text for Eikon:\n ",
    "published": "2018-04-12T02:23:00.000+03:00",
    "crawled": "2018-04-12T14:00:15.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "boehringer",
        "ingelheim",
        "boehringer",
        "ingelheim",
        "invest",
        "million",
        "avian",
        "vaccine",
        "boehringer",
        "ingelheim",
        "say",
        "set",
        "invest",
        "almost",
        "eur",
        "mln",
        "lyon",
        "site",
        "france",
        "rhône",
        "source",
        "text",
        "eikon"
    ]
}